Executive Development Programme in Innovative Pharma Market Access

-- ViewingNow

The Executive Development Programme in Innovative Pharma Market Access is a certificate course designed to address the growing need for experts in the pharmaceutical industry. This programme emphasizes the importance of market access in the pharma sector, focusing on innovative strategies and solutions to navigate the complex landscape.

4.5
Based on 2,004 reviews

7,468+

Students enrolled

GBP £ 140

GBP £ 202

Save 44% with our special offer

Start Now

ใ“ใฎใ‚ณใƒผใ‚นใซใคใ„ใฆ

With the increasing demand for cost-effective healthcare and personalized medicine, this course equips learners with essential skills to excel in their careers. It covers key topics such as health economics, pricing strategies, and reimbursement policies, providing a comprehensive understanding of market access challenges and opportunities. By completing this programme, learners will develop the ability to design and implement effective market access strategies, communicate persuasively with key stakeholders, and stay ahead of industry trends. This course is an excellent opportunity for professionals seeking to advance their careers in the pharmaceutical industry and make a meaningful impact on patient care and healthcare systems.

100%ใ‚ชใƒณใƒฉใ‚คใƒณ

ใฉใ“ใ‹ใ‚‰ใงใ‚‚ๅญฆ็ฟ’

ๅ…ฑๆœ‰ๅฏ่ƒฝใช่จผๆ˜Žๆ›ธ

LinkedInใƒ—ใƒญใƒ•ใ‚ฃใƒผใƒซใซ่ฟฝๅŠ 

ๅฎŒไบ†ใพใง2ใƒถๆœˆ

้€ฑ2-3ๆ™‚้–“

ใ„ใคใงใ‚‚้–‹ๅง‹

ๅพ…ๆฉŸๆœŸ้–“ใชใ—

ใ‚ณใƒผใ‚น่ฉณ็ดฐ

โ€ข Market Access
โ€ข Pharma Market Access Strategies
โ€ข Innovative Pharma Market Access
โ€ข Pricing and Reimbursement
โ€ข Health Economics and Outcomes Research
โ€ข Stakeholder Engagement in Pharma Market Access
โ€ข Regulatory and Policy Landscape in Pharma Market Access
โ€ข Digital and Real-World Evidence in Pharma Market Access
โ€ข Case Studies in Innovative Pharma Market Access
โ€ข Future Trends in Pharma Market Access

ใ‚ญใƒฃใƒชใ‚ขใƒ‘ใ‚น

The **Executive Development Programme in Innovative Pharma Market Access** features the following roles with their respective job market trends: - **Healthcare Consultant**: 25% of the market demand - **Market Access Manager**: 20% of the market demand - **Pricing & Reimbursement Specialist**: 18% of the market demand - **HEOR (Health Economics and Outcomes Research) Manager**: 15% of the market demand - **Market Access Associate**: 12% of the market demand - **Market Access Analyst**: 10% of the market demand These roles are essential in the ever-evolving pharmaceutical market access landscape, and this programme equips professionals with the necessary skills to thrive in these positions. Each role carries distinct responsibilities and opportunities, making them relevant and valuable in the UK's healthcare and pharmaceutical industries. The 3D pie chart above visualises these trends, offering a clear understanding of each role's significance in the market.

ๅ…ฅๅญฆ่ฆไปถ

  • ไธป้กŒใฎๅŸบๆœฌ็š„ใช็†่งฃ
  • ่‹ฑ่ชžใฎ็ฟ’็†Ÿๅบฆ
  • ใ‚ณใƒณใƒ”ใƒฅใƒผใ‚ฟใƒผใจใ‚คใƒณใ‚ฟใƒผใƒใƒƒใƒˆใ‚ขใ‚ฏใ‚ปใ‚น
  • ๅŸบๆœฌ็š„ใชใ‚ณใƒณใƒ”ใƒฅใƒผใ‚ฟใƒผใ‚นใ‚ญใƒซ
  • ใ‚ณใƒผใ‚นๅฎŒไบ†ใธใฎ็Œฎ่บซ

ไบ‹ๅ‰ใฎๆญฃๅผใช่ณ‡ๆ ผใฏไธ่ฆใ€‚ใ‚ขใ‚ฏใ‚ปใ‚ทใƒ“ใƒชใƒ†ใ‚ฃใฎใŸใ‚ใซ่จญ่จˆใ•ใ‚ŒใŸใ‚ณใƒผใ‚นใ€‚

ใ‚ณใƒผใ‚น็Šถๆณ

ใ“ใฎใ‚ณใƒผใ‚นใฏใ€ใ‚ญใƒฃใƒชใ‚ข้–‹็™บใฎใŸใ‚ใฎๅฎŸ็”จ็š„ใช็Ÿฅ่ญ˜ใจใ‚นใ‚ญใƒซใ‚’ๆไพ›ใ—ใพใ™ใ€‚ใใ‚Œใฏ๏ผš

  • ่ชๅฏใ•ใ‚ŒใŸๆฉŸ้–ขใซใ‚ˆใฃใฆ่ชๅฎšใ•ใ‚Œใฆใ„ใชใ„
  • ่ชๅฏใ•ใ‚ŒใŸๆฉŸ้–ขใซใ‚ˆใฃใฆ่ฆๅˆถใ•ใ‚Œใฆใ„ใชใ„
  • ๆญฃๅผใช่ณ‡ๆ ผใฎ่ฃœๅฎŒ

ใ‚ณใƒผใ‚นใ‚’ๆญฃๅธธใซๅฎŒไบ†ใ™ใ‚‹ใจใ€ไฟฎไบ†่จผๆ˜Žๆ›ธใ‚’ๅ—ใ‘ๅ–ใ‚Šใพใ™ใ€‚

ใชใœไบบใ€…ใŒใ‚ญใƒฃใƒชใ‚ขใฎใŸใ‚ใซ็งใŸใกใ‚’้ธใถใฎใ‹

ใƒฌใƒ“ใƒฅใƒผใ‚’่ชญใฟ่พผใฟไธญ...

ใ‚ˆใใ‚ใ‚‹่ณชๅ•

ใ“ใฎใ‚ณใƒผใ‚นใ‚’ไป–ใฎใ‚ณใƒผใ‚นใจๅŒบๅˆฅใ™ใ‚‹ใ‚‚ใฎใฏไฝ•ใงใ™ใ‹๏ผŸ

▼

ใ‚ณใƒผใ‚นใ‚’ๅฎŒไบ†ใ™ใ‚‹ใฎใซใฉใ‚Œใใ‚‰ใ„ๆ™‚้–“ใŒใ‹ใ‹ใ‚Šใพใ™ใ‹๏ผŸ

▼

WhatSupportWillIReceive

▼

IsCertificateRecognized

▼

WhatCareerOpportunities

▼

ใ„ใคใ‚ณใƒผใ‚นใ‚’้–‹ๅง‹ใงใใพใ™ใ‹๏ผŸ

▼

ใ‚ณใƒผใ‚นใฎๅฝขๅผใจๅญฆ็ฟ’ใ‚ขใƒ—ใƒญใƒผใƒใฏไฝ•ใงใ™ใ‹๏ผŸ

▼

ใ‚ณใƒผใ‚นๆ–™้‡‘

ๆœ€ใ‚‚ไบบๆฐ—
ใƒ•ใ‚กใ‚นใƒˆใƒˆใƒฉใƒƒใ‚ฏ๏ผš GBP £140
1ใƒถๆœˆใงๅฎŒไบ†
ๅŠ ้€Ÿๅญฆ็ฟ’ใƒ‘ใ‚น
  • ้€ฑ3-4ๆ™‚้–“
  • ๆ—ฉๆœŸ่จผๆ˜Žๆ›ธ้…้”
  • ใ‚ชใƒผใƒ—ใƒณ็™ป้Œฒ - ใ„ใคใงใ‚‚้–‹ๅง‹
Start Now
ใ‚นใ‚ฟใƒณใƒ€ใƒผใƒ‰ใƒขใƒผใƒ‰๏ผš GBP £90
2ใƒถๆœˆใงๅฎŒไบ†
ๆŸ”่ปŸใชๅญฆ็ฟ’ใƒšใƒผใ‚น
  • ้€ฑ2-3ๆ™‚้–“
  • ้€šๅธธใฎ่จผๆ˜Žๆ›ธ้…้”
  • ใ‚ชใƒผใƒ—ใƒณ็™ป้Œฒ - ใ„ใคใงใ‚‚้–‹ๅง‹
Start Now
ไธกๆ–นใฎใƒ—ใƒฉใƒณใซๅซใพใ‚Œใ‚‹ใ‚‚ใฎ๏ผš
  • ใƒ•ใƒซใ‚ณใƒผใ‚นใ‚ขใ‚ฏใ‚ปใ‚น
  • ใƒ‡ใ‚ธใ‚ฟใƒซ่จผๆ˜Žๆ›ธ
  • ใ‚ณใƒผใ‚นๆ•™ๆ
ใ‚ชใƒผใƒซใ‚คใƒณใ‚ฏใƒซใƒผใ‚ทใƒ–ไพกๆ ผ โ€ข ้š ใ‚ŒใŸๆ–™้‡‘ใ‚„่ฟฝๅŠ ่ฒป็”จใชใ—

ใ‚ณใƒผใ‚นๆƒ…ๅ ฑใ‚’ๅ–ๅพ—

่ฉณ็ดฐใชใ‚ณใƒผใ‚นๆƒ…ๅ ฑใ‚’ใŠ้€ใ‚Šใ—ใพใ™

ไผš็คพใจใ—ใฆๆ”ฏๆ‰•ใ†

ใ“ใฎใ‚ณใƒผใ‚นใฎๆ”ฏๆ‰•ใ„ใฎใŸใ‚ใซไผš็คพ็”จใฎ่ซ‹ๆฑ‚ๆ›ธใ‚’ใƒชใ‚ฏใ‚จใ‚นใƒˆใ—ใฆใใ ใ•ใ„ใ€‚

่ซ‹ๆฑ‚ๆ›ธใงๆ”ฏๆ‰•ใ†

ใ‚ญใƒฃใƒชใ‚ข่จผๆ˜Žๆ›ธใ‚’ๅ–ๅพ—

ใ‚ตใƒณใƒ—ใƒซ่จผๆ˜Žๆ›ธใฎ่ƒŒๆ™ฏ
EXECUTIVE DEVELOPMENT PROGRAMME IN INNOVATIVE PHARMA MARKET ACCESS
ใซๆŽˆไธŽใ•ใ‚Œใพใ™
ๅญฆ็ฟ’่€…ๅ
ใงใƒ—ใƒญใ‚ฐใƒฉใƒ ใ‚’ๅฎŒไบ†ใ—ใŸไบบ
London School of International Business (LSIB)
ๆŽˆไธŽๆ—ฅ
05 May 2025
ใƒ–ใƒญใƒƒใ‚ฏใƒใ‚งใƒผใƒณID๏ผš s-1-a-2-m-3-p-4-l-5-e
ใ“ใฎ่ณ‡ๆ ผใ‚’LinkedInใƒ—ใƒญใƒ•ใ‚ฃใƒผใƒซใ€ๅฑฅๆญดๆ›ธใ€ใพใŸใฏCVใซ่ฟฝๅŠ ใ—ใฆใใ ใ•ใ„ใ€‚ใ‚ฝใƒผใ‚ทใƒฃใƒซใƒกใƒ‡ใ‚ฃใ‚ขใ‚„ใƒ‘ใƒ•ใ‚ฉใƒผใƒžใƒณใ‚นใƒฌใƒ“ใƒฅใƒผใงๅ…ฑๆœ‰ใ—ใฆใใ ใ•ใ„ใ€‚
SSB Logo

4.8
ๆ–ฐ่ฆ็™ป้Œฒ
โ†’ ใ‚ณใƒผใ‚นใ‚’่ฆ‹ใ‚‹